Enovis ENOV
NYSE ENOV
$18.06 -0.21 (-1.15%)
As of: Oct 1, 2026 · 3:59 PM EDT

Enovis (ENOV) Current Deferred Revenue (2010 - 2016)

Updated

Enovis (ENOV) reported Current Deferred Revenue of $151.02 million for Q4 2016, down 22.6% from $195.04 million a year earlier.

Analysis

Enovis (ENOV) Current Deferred Revenue (2010 - 2016) Analysis & Trends

Dating back to Q4 2010, Enovis' Current Deferred Revenue record includes 6 quarters.

  • Current Deferred Revenue has a five-year compound annual growth rate of 59.3% (FY2011 to FY2016).
  • By year, Current Deferred Revenue came in at $195.04 million in FY2015.
  • The Q4 2016 figure ranks as the lowest quarterly Current Deferred Revenue since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Enovis 1.05 Bn 938.79 Mn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 151.02 Mn
Dec 31, 2015 195.04 Mn
Dec 31, 2011 14.70 Mn
Sep 30, 2011 13.58 Mn
Jul 1, 2011 22.19 Mn
Dec 31, 2010 17.25 Mn
API Access

Enovis Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ENOV&period=max&api_key=YOUR_API_KEY